ALK mutation did not affect the prognosis of NSCLC patients with BM, and the expressions of hsa_circ_0072309, miR‐100, and ACKR3 mRNAs and ACKR3 protein in serum. The gene discussed is ALK; the disease is non-small cell lung carcinoma.